BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 21354855)

  • 41. Saliva analysis by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) in orthodontic treatment: first pilot study.
    Ciavarella D; Mastrovincenzo M; D'Onofrio V; Chimenti C; Parziale V; Barbato E; Lo Muzio L
    Prog Orthod; 2011 Nov; 12(2):126-31. PubMed ID: 22074837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of a truncated cystatin SA-I as a saliva biomarker for oral squamous cell carcinoma using the SELDI ProteinChip platform.
    Shintani S; Hamakawa H; Ueyama Y; Hatori M; Toyoshima T
    Int J Oral Maxillofac Surg; 2010 Jan; 39(1):68-74. PubMed ID: 19896329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of colorectal cancer using MALDI-TOF serum protein profiling.
    de Noo ME; Mertens BJ; Ozalp A; Bladergroen MR; van der Werff MP; van de Velde CJ; Deelder AM; Tollenaar RA
    Eur J Cancer; 2006 May; 42(8):1068-76. PubMed ID: 16603345
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative study of matrices for their use in the rapid screening of anabolic steroids by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry.
    Galesio M; Rial-Otero R; Capelo-Martínez JL
    Rapid Commun Mass Spectrom; 2009 Jun; 23(12):1783-91. PubMed ID: 19444857
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapid identification of differentiation markers from whole epithelial cells by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry and statistical analysis.
    Marvin-Guy LF; Duncan P; Wagnière S; Antille N; Porta N; Affolter M; Kussmann M
    Rapid Commun Mass Spectrom; 2008 Apr; 22(8):1099-108. PubMed ID: 18335464
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.
    Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
    J Zhejiang Univ Sci B; 2006 Mar; 7(3):235-40. PubMed ID: 16502512
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new strategy to screen molecular imaging probe uptake in cell culture without radiolabeling using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Cheng Z; Winant RC; Gambhir SS
    J Nucl Med; 2005 May; 46(5):878-86. PubMed ID: 15872363
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Liu LH; Shan BE; Tian ZQ; Sang MX; Ai J; Zhang ZF; Meng J; Zhu H; Wang SJ
    Clin Chem Lab Med; 2010 Jun; 48(6):855-61. PubMed ID: 20345231
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages.
    Jou YJ; Lin CD; Lai CH; Tang CH; Huang SH; Tsai MH; Chen SY; Kao JY; Lin CW
    Clin Chim Acta; 2011 Jul; 412(15-16):1357-65. PubMed ID: 21497587
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
    Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
    Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
    Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
    Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MALDI MS profiling of post-DRE urine samples highlights the potential of β-microseminoprotein as a marker for prostatic diseases.
    Flatley B; Wilmott KG; Malone P; Cramer R
    Prostate; 2014 Jan; 74(1):103-11. PubMed ID: 24115268
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined experimental and statistical strategy for mass spectrometry based serum protein profiling for diagnosis of breast cancer: a case-control study.
    Callesen AK; Vach W; Jørgensen PE; Cold S; Tan Q; Depont Christensen R; Mogensen O; Kruse TA; Jensen ON; Madsen JS
    J Proteome Res; 2008 Apr; 7(4):1419-26. PubMed ID: 18303830
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surface-enhanced Laser Desorption/Ionisation Time-of-flight Mass Spectrometry to Detect Breast Cancer Markers in Tears and Serum.
    Lebrecht A; Boehm D; Schmidt M; Koelbl H; Grus FH
    Cancer Genomics Proteomics; 2009; 6(2):75-83. PubMed ID: 19451091
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Application of matrix assisted laser desorption ionization-time of flight-mass spectrometry in detecting K-ras gene mutation of colorectal cancer].
    Xing JD; Zhang LH; Li JJ; Li ZY; Su XQ; Ji JF
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jan; 16(1):80-3. PubMed ID: 23355247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
    Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
    Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Exploration of Peptide Biomarkers in Malignant Pleural Effusion of Lung Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry.
    Xu J; Xu B; Tang C; Li X; Qin H; Wang W; Wang H; Wang Z; Li L; Li Z; Gao H; He K; Liu X
    Dis Markers; 2017; 2017():3160426. PubMed ID: 28386154
    [No Abstract]   [Full Text] [Related]  

  • 59. Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry.
    Hu S; Yu T; Xie Y; Yang Y; Li Y; Zhou X; Tsung S; Loo RR; Loo JR; Wong DT
    Cancer Genomics Proteomics; 2007; 4(2):55-64. PubMed ID: 17804867
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Beyond identification: emerging and future uses for MALDI-TOF mass spectrometry in the clinical microbiology laboratory.
    DeMarco ML; Ford BA
    Clin Lab Med; 2013 Sep; 33(3):611-28. PubMed ID: 23931841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.